|
CRLS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.963600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.290000E-02 |
| Normal-vs-Stage2 |
2.539900E-02 |
| Normal-vs-Stage3 |
1.146800E-01 |
| Normal-vs-Stage4 |
1.436140E-02 |
| Stage1-vs-Stage2 |
3.670400E-01 |
| Stage1-vs-Stage3 |
8.147400E-01 |
| Stage1-vs-Stage4 |
3.134400E-01 |
| Stage2-vs-Stage3 |
3.630400E-01 |
| Stage2-vs-Stage4 |
9.591400E-01 |
| Stage3-vs-Stage4 |
3.098800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.286300E-02 |
| Normal-vs-AfricanAmerican |
5.659800E-02 |
| Normal-vs-Asian |
1.281770E-01 |
| Caucasian-vs-AfricanAmerican |
6.974600E-01 |
| Caucasian-vs-Asian |
5.343400E-01 |
| AfricanAmerican-vs-Asian |
4.346200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.795600E-02 |
| Normal-vs-Female |
3.638000E-02 |
| Male-vs-Female |
8.267000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.163800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.540000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.213850E-02 |
| Normal-vs-Age(81-100Yrs) |
8.782600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.153600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.361200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.685800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.609400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.120800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.769000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.302200E-01 |
| Classical-VS-Follicular |
4.329600E-02 |
| Classical-VS-Other |
8.609000E-01 |
| Classical-VS-Normal |
1.432770E-01 |
| Tall-VS-Follicular |
2.705200E-01 |
| Tall-VS-Other |
9.135000E-01 |
| Tall-VS-Normal |
3.079000E-01 |
| Follicular-VS-Other |
6.224800E-01 |
| Follicular-VS-Normal |
1.186260E-02 |
| Other-VS-Normal |
4.710000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.303100E-03 |
| Normal-vs-N1 |
1.532040E-01 |
| N0-vs-N1 |
3.556600E-01 |
|
|
